JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Ulrich Grau, President and CEO, will present a company overview at the Lazard Capital Markets 5th Annual Healthcare Conference on Wednesday, November 19th, 2008, at 10:30 AM ET in New York City.
